Alex Wu

Alex focuses her practice on initial public offerings, venture capital, mergers and acquisitions, and general corporate matters.

Alex is a native Mandarin speaker and is fluent in English. 

Representative Matters:

Capital Markets

• WeRide, a global leader in autonomous driving technology, in its HK$2.39 billion IPO and listing on the HKEX
• Leads Biolabs, a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies to address unmet medical needs in oncology, autoimmune, and other severe diseases both in China and globally, with a particular focus on diseases that remain untreated by existing therapies, represented by PD-1/PD-L1, in its HK$1.29 billion IPO and listing on the HKEX
• VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, in its HK$783 million IPO and listing on the HKEX
• Hangzhou Jiuyuan Gene Engineering, a leading biopharmaceutical company in China, in its HK$563 million IPO and listing on the HKEX
• Morgan Stanley and CICC as underwriters in Taimei Technology’s HK$335 million IPO and listing on the HKEX
• ImmuneOnco Biopharmaceuticals in its HK$319 million IPO and listing on the HKEX
• Citi and Huatai International as underwriters in Cryofocus Medtech’s HK$210 million IPO and listing on the HKEX
• Vietnam Sunergy Cell Company Limited (TOYO Solar), a Vietnam solar solution company originating from the Bloomberg Tier 1 listed solar module producer, Vietnam Sunergy Joint Stock Company (VSUN), in its business combination with Blue World Acquisition Corporation (SPAC)
• Sichuan Biokin Pharmaceutical, a leading biopharmaceutical company in China, in its proposed IPO and listing on the HKEX (on-going)
• Woodpecker International, a leading home maintenance and repair platform in China, in its proposed IPO and listing on the HKEX (on-going)
• Country Style Cooking, a leading restaurant chain in China, in its proposed IPO and listing on the HKEX (on-going)

Compliance

• Autohome Inc. (NYSE: ATHM; HKEX: 2518) in its post-listing compliance matter
• FUTU Holdings (Nasdaq: FUTU) in its post-listing compliance matter
• ZKH Group Limited (NYSE: ZKH) in its post-listing compliance matter
• Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) in its post-listing compliance matter
• Hangzhou Jiuyuan Gene Engineering (HKEX: 2566) in its post-listing compliance matter
• VISEN Pharmaceuticals (HKEX: 2561) in its post-listing compliance matter